February 2026
1. REN K, Cong Y, Jin Y, Zhou T, et al
   Inflammatory bowel disease burden in Six Different Dietary Regions and Worldwide.
   Dig Dis. 2026 Feb 20:1-37. doi: 10.1159/000550714.
   

   >> Share

   
   January 2026
2. JUD N, Biedermann L, Kreienbuehl AS, Pagkalidou E, et al
   Clinical Utility of Intestinal Ultrasound for Guiding Therapy in Inflammatory Bowel Disease: A Retrospective Real-World Cohort from a Swiss Tertiary Center.
   Dig Dis. 2026;44:42-49.
   

   >> Share

   
   December 2025
3. SARBAGILI-SHABAT C, Zelber-Sagi S, Fliss Isakov N, Hirsch A, et al
   Physical activity is inversely associated with clinical exacerbation in patients with Crohn's disease in remission - a prospective cohort study.
   Dig Dis. 2025 Dec 11:1-14. doi: 10.1159/000550048.
   

   >> Share

   
   October 2025
4. MEIR Y, Leibovitzh H, Shaham D, Hirsch A, et al
   Effectiveness of the Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease in the Older-Adult Population: Real-World Experience.
   Dig Dis. 2025 Oct 20:1-21. doi: 10.1159/000548931.
   

   >> Share

   
   
5. DOUKAS PG, Doukas SG, Broder A
   Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis.
   Dig Dis. 2025 Oct 10:1-22. doi: 10.1159/000548568.
   

   >> Share

   
   August 2025
6. REGUEIRO M, Gulati T, Bandyopadhyay A, Fisher DA, et al
   Real-world Dose Escalation and Associated Direct Costs of Biologics in Management of Ulcerative Colitis: A Retrospective Database Study.
   Dig Dis. 2025 Aug 16:1-16. doi: 10.1159/000547994.
   

   >> Share

   
   
7. FERREIRA AI, Capela TL, Xavier S, Arieira C, et al
   Tailoring Crohn's disease surveillance in clinical remission: new insights from the Lewis score.
   Dig Dis. 2025 Aug 4:1-19. doi: 10.1159/000546541.
   

   >> Share

   
   June 2025
8. HAYASAKA J, Matsui A, Kikuchi D, Hoteya S, et al
   Impact of therapeutic agents on serum leucine-rich alpha-2 glycoprotein for monitoring endoscopically remitted ulcerative colitis.
   Dig Dis. 2025 Jun 24:1-22. doi: 10.1159/000547007.
   

   >> Share

   
   May 2025
9. SARBAGILI-SHABAT C, Zelber-Sagi S, Fliss Isakov N, Hirsch A, et al
   High ultra-processed food consumption is associated with clinical exacerbation in patients with Crohn's disease in remission - a prospective cohort study.
   Dig Dis. 2025 May 20:1-17. doi: 10.1159/000546486.
   

   >> Share

   
   February 2025
10. DE GREEF I, Bislenghi G, Terrasson I, Sabino J, et al
    No increased risk of venous thromboembolism or infectious complications after JAK inhibitor exposure in patients with ulcerative colitis undergoing surgery.
    Dig Dis. 2025 Feb 27:1-21. doi: 10.1159/000544062.
    

    >> Share

    
    
11. ZHANG H, Xiang J, Feng J, Zhang M, et al
    Gut microbiome dysbiosis and inflammatory bowel disease complement each other.
    Dig Dis. 2025 Feb 25:1-18. doi: 10.1159/000544771.
    

    >> Share

    
    November 2024
12. CLASSEN JM, Muzalyova A, Rommele C, Nagl S, et al
    Antibody response to SARS-CoV2 before and after the third vaccination in patients with Inflammatory Bowel Disease.
    Dig Dis. 2024 Nov 30:1-19. doi: 10.1159/000542353.
    

    >> Share

    
    
13. ZHANG Q, Lou D, Zhang Y, Xu A, et al
    A Meta-Analysis of Proton Pump Inhibitor Exposure and the Risk of Adverse Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis. 2024 Nov 21:1-16. doi: 10.1159/000542729.
    

    >> Share

    
    
14. MATTILA J, Kallio J, Loyttyniemi E, Nuutila P, et al
    Combined [18F]-FDG PET-MR Imaging: A promising tool for diagnostics of small bowel Crohn's disease.
    Dig Dis. 2024 Nov 13:1-23. doi: 10.1159/000542379.
    

    >> Share

    
    October 2024
15. MATSUMOTO S, Mashima H
    Clinical profiles of leucine-rich alpha-2 glycoprotein for indicating mucosal healing in ulcerative colitis patients under administration of molecular targeted drug.
    Dig Dis. 2024 Oct 25:1-18. doi: 10.1159/000542062.
    

    >> Share

    
    August 2024
16. GINARD D, Barreiro-de Acosta M, Nos P, Moraleja I, et al
    Efficacy of beclomethasone dipropionate in lowering fecal calprotectin levels in patients with ulcerative colitis in clinical remission and at risk of relapse: The Becalcu randomized, controlled trial.
    Dig Dis. 2024 Aug 22. doi: 10.1159/000540792.
    

    >> Share

    
    May 2024
17. CAPPUCCIO JM, Mehta N, Pellish R
    Inpatient Infliximab Biosimilar Cost-Savings - Cost analysis of inpatient treatment with originator Infliximab (Remicade) vs biosimilar Infliximab (Renflexis) for acute severe ulcerative colitis.?.
    Dig Dis. 2024 May 24. doi: 10.1159/000536303.
    

    >> Share

    
    March 2024
18. GUERRA I, Barros F, Chaparro M, Benitez JM, et al
    Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
    Dig Dis. 2024 Mar 7. doi: 10.1159/000537782.
    

    >> Share

    
    January 2024
19. SOKIC-MILUTINOVIC A, Milosavljevic T
    Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy.
    Dig Dis. 2024;42:325-335.
    

    >> Share

    
    December 2023
20. SIGALL BONEH R, Assa A, Lev-Tzion R, Matar M, et al
    Adherence to the Mediterranean diet is associated with decreased Fecal Calprotectin Levels in Children with Crohn's Disease in Clinical Remission under biological Therapy.
    Dig Dis. 2023 Dec 1. doi: 10.1159/000535540.
    

    >> Share

    
    September 2023
21. YANG MM, Usiskin K, Ahmad HA, Ather S, et al
    Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials.
    Dig Dis. 2023 Sep 27. doi: 10.1159/000533395.
    

    >> Share

    
    
22. BOLDOVJAKOVA D, El-Abbassy I, Alarcon I, El-Saify M, et al
    Management of the Rectal Stump after Subtotal Colectomy Operations for Inflammatory Bowel Disease in the Era of Immunologic Therapy: A Two-Centre Cohort Study.
    Dig Dis. 2023 Sep 8:1-7. doi: 10.1159/000533267.
    

    >> Share

    
    August 2023
23. BASTIDA PAZ G, Merino Ochoa O, Aguas Peris M, Barreiro-de Acosta M, et al
    The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making.
    Dig Dis. 2023 Aug 23:1-11. doi: 10.1159/000531789.
    

    >> Share

    
    June 2023
24. NERI B, Russo C, Mossa M, Martire FG, et al
    High Frequency of Deep Infiltrating Endometriosis in Patients with Inflammatory Bowel Disease: A Nested Case-Control Study.
    Dig Dis. 2023 Jun 30:1. doi: 10.1159/000530896.
    

    >> Share

    
    
25. SURDEA-BLAGA T, Ismaiel A, Jaaouani A, Leucuta DC, et al
    Adiponectin Levels in Inflammatory Bowel Disease - A Systematic Review and Meta-analysis.
    Dig Dis. 2023 Jun 29. doi: 10.1159/000531614.
    

    >> Share

    
    
26. SHI H, Zeng H, Wang M, Jiang J, et al
    Effectiveness of water-assisted colonoscopy without sedation in patients with ulcerative colitis.
    Dig Dis. 2023 Jun 27. doi: 10.1159/000531652.
    

    >> Share

    
    March 2023
27. SALEH A, Parsa S, Garza M, Quigley EMM, et al
    The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis.
    Dig Dis. 2023 Mar 1. doi: 10.1159/000529591.
    

    >> Share

    
    January 2023
28. HELWIG U, Krause TH, Maaser C, Buning J, et al
    Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial.
    Dig Dis. 2023;41:239-249.
    

    >> Share

    
    
29. PELEG N, Yanai H, Gingold-Belfer R, Dotan I, et al
    Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience.
    Dig Dis. 2023;41:233-238.
    

    >> Share

    
    
30. KRAL J, Nakov R, Lanska V, Barberio B, et al
    Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey.
    Dig Dis. 2023;41:387-395.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share